<DOC>
	<DOCNO>NCT00070616</DOCNO>
	<brief_summary>Open label palifermin administer subject risk develop mucositis radiotherapy chemotherapy follow blood stem cell support . The amount palifermin blood follow administration evaluate . The safety palifermin administration effect reduce mucositis also evaluate .</brief_summary>
	<brief_title>Pharmacokinetic Study Palifermin Subjects Receiving Radiation Therapy Chemotherapy Followed Blood Stem Cell Support</brief_title>
	<detailed_description>Mucositis common side effect chemotherapy radiotherapy involve formation erythema ulcerative lesion mouth . Mucositis serious , result pain require intervention analgesic medication use parenteral feeding . Currently , standard therapy available prevent treat mucositis .</detailed_description>
	<criteria>Patients diagnose NonHodgkin 's Lymphoma , Hodgkin 's Disease , Leukemia Myeloma . Eligible treatment radiation therapy chemotherapy follow blood stem cell support .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>76 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>mucositis</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>radiation therapy</keyword>
</DOC>